3 ms·
> thus improving life expectancy and quality of life, while lowering associated medical costs Be careful with this. Look into the result of increase PSA testin
by dehrmann 8y ago
> thus improving life expectancy and quality of life, while lowering associated medical costs
Be careful with this. Look into the result of increase PSA testing:
> Although experts are somewhat split on the value of PSA tests as a screening tool, there is widespread agreement on two major points: overdiagnosis and overtreatment rates are far too high, and there is an urgent need to refine PSA testing to be a more effective screening tool. [1]
Or mammograms
> We conclude that the mammography FP rate in North America is in excess... [2]
Arguably, the issue is that we just lack good baseline data, but you have to consider all the false positives you'll get with more data collection.
[1]: https://www.health.harvard.edu/healthbeat/the-pros-and-cons-of-psa-screening https://www.health.harvard.edu/healthbeat/the-pros-and-cons-...
[2]: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5124917/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5124917/